Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Q wave myocardial infarction.

S Borzak1, H S Rosman

  • 1Heart and Vascular Institute, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI 48202.

Henry Ford Hospital Medical Journal
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study.

Circulation·2001
Same author

Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics.

American heart journal·2001
Same author

Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.

Circulation·2001
Same author

Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence.

Progress in cardiovascular diseases·2001
Same author

Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?

Chest·2001

Non-Q wave myocardial infarction presents lower initial mortality but higher reinfarction risk. Identifying high-risk patients allows for aggressive revascularization therapy, though further research on secondary prevention is needed.

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • Non-Q wave myocardial infarction (NQMI) is a distinct clinical entity.
  • NQMI is characterized by lower initial mortality but a higher reinfarction rate compared to Q wave infarction.
  • Pathological data suggest NQMI results from transient or incomplete coronary occlusion, leading to smaller infarcts.

Purpose of the Study:

  • To review existing clinical trials on NQMI.
  • To suggest management guidelines for NQMI patients.
  • To identify high-risk patients for aggressive therapy.

Main Methods:

  • Review of clinical trials focusing on initial therapy and secondary prevention in NQMI.
  • Analysis of clinical and pathological data to understand NQMI characteristics.
  • Identification of high-risk patient profiles during hospitalization.

Related Experiment Videos

Main Results:

  • NQMI patients have a lower initial mortality rate.
  • NQMI patients experience a higher rate of reinfarction.
  • High-risk patients can be identified for targeted interventions.

Conclusions:

  • NQMI is a dynamic condition requiring specific management strategies.
  • Aggressive therapy, including revascularization, is recommended for identified high-risk NQMI patients.
  • Further clinical trials are needed to optimize secondary prevention in NQMI.